NEW YORK, Nov. 20, 2014 /PRNewswire/ -- Morgan & Morgan announces that it is investigating potential claims against the Board of Directors of Covance, Inc. ("Covance" or the "Company") (NYSE: CVD) relating to the proposed acquisition by Laboratory Corporation of America Holdings ("LabCorp").

If you own shares of Covance and want more information about the Covance investigation, contact Morgan & Morgan at 1(800) 732-5200 or email info@morgansecuritieslaw.com

Under the terms of the transaction, Covance shareholders will receive only 0.2686 shares of Labcorp stock and $75.76 in cash for each share of Covance stock they own. Morgan & Morgan is investigating whether the Company's Board of Directors breached their fiduciary duties by failing to maximize shareholder value and/or protect the interests of Covance shareholders.

Morgan & Morgan is one of the nation's largest 200 law firms. In addition to securities fraud, the firm also practices in the areas of antitrust, personal injury, consumer protection, overtime, and product liability. All of the Firm's legal endeavors are rooted in its core mission: provide investor and consumer protection and always fight "for the people."

Attorney advertising. Prior results do not guarantee a similar outcome.

Contact:
Morgan & Morgan
Peter Safirstein, Esq.
28 West 44(th) Street
Suite 2001
New York, NY 10036
1-800-732-5200
info@morgansecuritieslaw.com

SOURCE Morgan & Morgan